BIOPATCH™ Protective Disk with CHG
BIOPATCH™ Protective Disk with CHG
In the US each year, there are an estimated 250,000 Central Line‐Associated Bloodstream Infections, with up to 33,000 deaths and a potential cost of $1 billion to the health care system.1 BIOPATCH™ is the only dressing that is designed to deliver chlorhexidine gluconate a full 360 degrees around the catheter insertion site, providing optimized coverage and protection.2,3 It is the only sponge dressing with a cleared indication for the reduction of CRBSIs in central venous and arterial catheters, with proven clinical efficacy.3,4
MEDIA
In the US each year, there are an estimated 250,000 Central Line‐Associated Bloodstream Infections, with up to 33,000 deaths and a potential cost of $1 billion to the health care system.1 BIOPATCH™ is the only dressing that is designed to deliver chlorhexidine gluconate a full 360 degrees around the catheter insertion site, providing optimized coverage and protection.2,3 It is the only sponge dressing with a cleared indication for the reduction of CRBSIs in central venous and arterial catheters, with proven clinical efficacy.3,4
About this Device
BIOPATCH™ is a hydrophilic polyurethane absorptive foam with chlorhexidine gluconate (CHG). The foam material absorbs up to eight times its own weight in fluid, while the CHG incorporated into the dressing inhibits bacterial growth under the dressing. Chlorhexidine gluconate is a well-known antiseptic agent with broad-spectrum antimicrobial and antifungal activity.3
Economic Evidence
The cost of a catheter-related bloodstream infection (CRBSI) is higher than the price of preventing it. A single CRBSI can cost up to $45,814, on average. Chlorhexidine-impregnated sponges for arterial and central venous catheters may save money by reducing major catheter-related infections.10,11
A controlled, randomized, clinical trial consisting of 687
subjects with 1699 central venous or arterial catheter
insertion sites was conducted at two centers. Results showed that the use of BIOPATCH™ had a3:
- 44% reduction in the incidence of local infection (p≤0.0001)
- 60% reduction in the incidence of catheter-related blood stream infections (p=0.026)
Clinical Evidence
BIOPATCH™ has a cleared indication to reduce the
incidence of Catheter Related Bloodstream Infections (CRBSIs), local infections, and skin colonization in patients with central venous and arterial catheters.2,3
Only BIOPATCH™ has over 30 years of extensive
clinical experience5, with more than3,6-9:
- 15 randomized controlled trials
- 13 Level II forms of evidence
- 6 Level III forms of evidence
Features & Benefits
Lasting Protection
Proprietary engineered polyurethane composite material is designed to continuously release CHG over 7 days to maintain skin antisepsis.6
360 Degree Coverage
Designed to deliver chlorhexidine gluconate a full 360 degrees around the catheter insertion site providing optimized coverage and protection.2,3 It is trusted by more than 60% of hospitals in the US.A12
Easy to Use
BIOPATCH™ dressing is easy to apply and remove. Removal of BIOPATCH is a simple, one-step process with no saline or alcohol swabs needed.3
Device Specifications and Comparisons
Device Specifications and Comparisons
BIOPATCH™ containing Chlorhexidine Gluconate is intended for use as a hydrophilic wound dressing that is used to absorb exudate and to cover a wound caused by the use of vascular and non-vascular percutaneous medical devices such as: IV catheters, central venous lines, arterial catheters, dialysis catheters, peripherally inserted coronary catheters, mid-line catheters, drains, chest tubes, externally placed orthopedic pins, and epidural catheters. It is also intended to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI, in patients with central venous or arterial catheters.3
Select Competitive Products: 3M™ Tegaderm™ CHG, Becton Dickinson GuardIVa™ Antimicrobial Hemostatic IV Dressing, STATSEAL®, KendallTM AMD Antimicrobial Foam Disc Dressing, Covalon IV Clear™, HydroLogic Systems CHLORASHIELD®, DeRoyal ALGIDEX™ Ag I.V. Patch and Medline AEGIS™ CHG Disk
Featured Product |
||
|
|
|
|
BIOPATCH™ Protective Disk with CHG |
Not Applicable |
|
|---|---|---|
Codes |
|
— |
Disk Diameter |
|
— |
Center Hole Diameter |
|
— |
French Size Range |
|
— |
Average CHG per disk |
|
— |
Common Uses |
|
— |
Quantity per Box |
10 |
— |
Quantity per Case |
40 (4 boxes |
— |
Supporting Documentation
Evidence Resources
Product Resources
-
BIOPATCH™ 510(k)
View 510(k)
-
BIOPATCH™ Arterial Line Brochure
View PDF
-
BIOPATCH™ Drain Fact Sheet
View PDF
-
BIOPATCH™ Inservice Brochure
View PDF
-
BIOPATCH™ Overview
View PDF
-
BIOPATCH™ Point Prevalence Overview
View PDF
-
BIOPATCH™ Product Brochure
View PDF
-
BIOPATCH™ Visualization (with PIV) Guide
View PDF
-
BIOPATCH™ vs. AEGIS™ CHG Disk Competitive Overview
View PDF
-
BIOPATCH™ vs. GuardIVa Competitive Overview
View PDF
-
BIOPATCH™ vs. Tegaderm CHG Competitive Overview
View PDF
-
Competitive Percutaneous Site Dressings Overview
View PDF
-
Select all documents (11)
© Ethicon US, LLC. 2022.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.